1 Day CRBP -2.32% DJIA -0.07% Russell 2K 0.00% Health Care/Life Sciences -0.02% ...

Shares of CRBP stock opened at $11.30 on Monday. Corbus Pharmaceuticals has a 52-week low of $5.67 and a 52-week high of $61.90. The stock has a market cap of $137.62 million, a price-to-earnings ...

Piper Sandler has initiated coverage of Corbus Pharmaceuticals (NASDAQ:CRBP) and Viking Therapeutics (NASDAQ:VKTX) with overweight ratings. The investment bank said it believes Corbus’s (CRBP ...

CRBP stock opened at $11.79 on Monday. The business has a 50 day moving average price of $15.40 and a 200 day moving average price of $32.95. The stock has a market cap of $143.59 million, a price ...

Find the latest Corbus Pharmaceuticals Holdings CRBP analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) stock has reached a 52-week low, dipping to $10.43. With a beta of 2.64 and a trading range of $7.49 to $61.90 over the past... ByInvesting.com ...

Piper Sandler analyst Biren Amin maintained a Buy rating on Corbus Pharmaceuticals (CRBP – Research Report) today and set a price target of $35.00. The company’s shares closed yesterday at $9.90.

1 Day CRBP -1.11% DJIA -0.75% Russell 2K -0.86% Health Care/Life Sciences 0.29% ...

NORWOOD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval ...